{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:31:37Z","timestamp":1787167897033,"version":"build-2736575974"},"reference-count":41,"publisher":"e-Century Publishing Corporation","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/detb5846","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:28:32Z","timestamp":1756373312000},"page":"6442-6452","source":"Crossref","is-referenced-by-count":1,"title":["A comparative study of the efficacy of an ultra-picosecond laser versus an ultra-pulsed CO2 laser in the treatment of xanthelasma palpebrarum"],"prefix":"10.62347","volume":"17","author":[{"given":"Jing","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1111\/jocd.13366","article-title":"Clinical and serum lipid profiles and LDLR genetic analysis of xanthelasma palpebrarum with nonfamilial hypercholesterolemia","volume":"19","author":"Zhimin","year":"2020","unstructured":"Zhimin W, Hui W, Fengtao J, Wenjuan S and Yongrong L. Clinical and serum lipid profiles and LDLR genetic analysis of xanthelasma palpebrarum with nonfamilial hypercholesterolemia. J Cosmet Dermatol 2020; 19: 3096-3099.","journal-title":"J Cosmet Dermatol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00403-024-02863-y","article-title":"Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities","volume":"316","author":"DA","year":"2024","unstructured":"Yee DA, Zhou AE and Khachemoune A. Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities. Arch Dermatol Res 2024; 316: 149.","journal-title":"Arch Dermatol Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s00403-024-03298-1","article-title":"A scoring-based clinical grading model for xanthelasma palpebrarum: predicting treatment frequency and prognosis","volume":"316","author":"Xu","year":"2024","unstructured":"Xu Q, Yao Z, Yu X, Ying J, Zhu J, Lu L, Hu Z, Jiang H and Wang H. A scoring-based clinical grading model for xanthelasma palpebrarum: predicting treatment frequency and prognosis. Arch Dermatol Res 2024; 316: 614.","journal-title":"Arch Dermatol Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/bjo-2024-325581","article-title":"Carbon dioxide laser excision as a novel treatment for large xanthelasma palpebrarum: long-term efficacy and safety","volume":"109","author":"Wang","year":"2025","unstructured":"Wang D, Mao Z, Li Z, Gao W, Qu Y, Li X, Jiang Y and Lin X. Carbon dioxide laser excision as a novel treatment for large xanthelasma palpebrarum: long-term efficacy and safety. Br J Ophthalmol 2025; 109: 427-432.","journal-title":"Br J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/clinpract13050108","article-title":"Digital patient education on xanthelasma palpebrarum: a content analysis","volume":"13","author":"Varghese","year":"2023","unstructured":"Varghese KJ, Singh SP, Qureshi FM, Shreekumar S, Ramprasad A and Qureshi F. Digital patient education on xanthelasma palpebrarum: a content analysis. Clin Pract 2023; 13: 1207-1214.","journal-title":"Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/photob.2020.4874","article-title":"A Comparison of efficacy and safety of fractional carbon dioxide laser and fractional Er:YAG laser for the treatment of xanthelasma palpebrarum: a two-center randomized split-face controlled trial","volume":"39","author":"Tuan","year":"2021","unstructured":"Tuan H, Chen Y, Yang S, Liu D, Chen D and Zhao Y. A Comparison of efficacy and safety of fractional carbon dioxide laser and fractional Er:YAG laser for the treatment of xanthelasma palpebrarum: a two-center randomized split-face controlled trial. Photobiomodul Photomed Laser Surg 2021; 39: 131-136.","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1111\/jocd.13678","article-title":"Successful treatment of xanthelasma palpebrarum with a combination of radiofrequency ablation and wound suturing","volume":"19","author":"Singh","year":"2020","unstructured":"Singh A, Tiwary PK, Jha AK, Zeeshan M and Ranjan A. Successful treatment of xanthelasma palpebrarum with a combination of radiofrequency ablation and wound suturing. J Cosmet Dermatol 2020; 19: 3286-3290.","journal-title":"J Cosmet Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1111\/jocd.13930","article-title":"Xanthelasma palpebrarum after hyaluronic acid injection in the lower eyelid: a case report and review of the literature","volume":"20","author":"Sim&#xF5","year":"2021","unstructured":"Simões Pires V, Wender IO, Santos MF, Sartori GL, Vivian A and Dallagnese G. Xanthelasma palpebrarum after hyaluronic acid injection in the lower eyelid: a case report and review of the literature. J Cosmet Dermatol 2021; 20: 2750-2752.","journal-title":"J Cosmet Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Scarano A, Inchingolo F, Scogna G, Leo L, Crisante A, Greco Lucchina A and Lorusso F. Xanthelasma palpebrarum removed with atmospheric plasma technique: 11-year follow up. J Biol Regul Homeost Agents 2021; 35 Suppl 1: 181-185.","DOI":"10.23812\/21-2supp1-18"},{"key":"ref9","unstructured":"Sapra S, Tran JV, Gurm H and Eleuterio M. Treatment of xanthelasma palpebrarum using trichloroacetic acid 80. J Clin Aesthet Dermatol 2024; 17: 17-22."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15570\/actaapa.2020.13","article-title":"Plasma sublimation for the treatment of xanthelasma palpebrarum","volume":"29","author":"Rubins","year":"2020","unstructured":"Rubins S, Ritina I, Jakus J and Rubins A. Plasma sublimation for the treatment of xanthelasma palpebrarum. Acta Dermatovenerol Alp Pannonica Adriat 2020; 29: 55-57.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/DSS.0000000000003078","article-title":"An updated work-up for patients with xanthelasma palpebrarum","volume":"47","author":"Rothstein","year":"2021","unstructured":"Rothstein BE and Cohen JL. An updated work-up for patients with xanthelasma palpebrarum. Dermatol Surg 2021; 47: 1170-1171.","journal-title":"Dermatol Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.31729\/jnma.7485","article-title":"Dyslipidemia in patients with xanthelasma palpebrarum visiting the department of dermatology of a tertiary care centre: a descriptive cross-sectional study","volume":"60","author":"Rai","year":"2022","unstructured":"Rai A, Karki S, Prasad Sah S, Narayan Kamat L and Pradhan M. Dyslipidemia in patients with xanthelasma palpebrarum visiting the department of dermatology of a tertiary care centre: a descriptive cross-sectional study. JNMA J Nepal Med Assoc 2022; 60: 529-532.","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.25259\/IJDVL_339_2023","article-title":"Successful treatment of xanthelasma palpebrarum grade III with copper vapour laser radiation (578 nm)","volume":"91","author":"IV","year":"2025","unstructured":"Ponomarev IV, Topchiy SB and Shakina LD. Successful treatment of xanthelasma palpebrarum grade III with copper vapour laser radiation (578 nm). Indian J Dermatol Venereol Leprol 2025; 91: 236-237.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1111\/jocd.15880","article-title":"Successful treatment of xanthelasma palpebrarum with copper vapor laser radiation at 578 nm","volume":"22","author":"IV","year":"2023","unstructured":"Ponomarev IV, Topchiy SB and Shakina LD. Successful treatment of xanthelasma palpebrarum with copper vapor laser radiation at 578 nm. J Cosmet Dermatol 2023; 22: 3522-3523.","journal-title":"J Cosmet Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Rohrich RJ, Janis JE and Pownell PH. Xanthelasma palpebrarum: a review and current management principles. Plast Reconstr Surg 2002; 110: 1310-1314.","DOI":"10.1097\/00006534-200210000-00016"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5999\/aps.2013.40.4.380","article-title":"Outcomes of surgical management of xanthelasma palpebrarum","volume":"40","author":"Lee","year":"2013","unstructured":"Lee HY, Jin US, Minn KW and Park YO. Outcomes of surgical management of xanthelasma palpebrarum. Arch Plast Surg 2013; 40: 380-386.","journal-title":"Arch Plast Surg"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Nagamatsu S, Sasaki A, Uchiki T, Kawamoto H and Yokota K. An angled mirror device facilitates measurement of skin lesion height. Plast Reconstr Surg Glob Open 2020; 8: e3233.","DOI":"10.1097\/GOX.0000000000003233"},{"key":"ref18","unstructured":"LE WJFsDiGMteNYMH. Xanthomatoses and lipoprotein disorders 2008; 1272."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1097\/DSS.0000000000000172","article-title":"Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial","volume":"40","author":"Esmat","year":"2014","unstructured":"Esmat SM, Elramly AZ, Abdel Halim DM, Gawdat HI and Taha HI. Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial. Dermatol Surg 2014; 40: 1349-1355.","journal-title":"Dermatol Surg"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.burns.2015.04.018","article-title":"What score on the vancouver scar scale constitutes a hypertrophic scar? Results from a survey of north American burn-care providers","volume":"41","author":"Thompson","year":"2015","unstructured":"Thompson CM, Sood RF, Honari S, Carrougher GJ and Gibran NS. What score on the vancouver scar scale constitutes a hypertrophic scar? Results from a survey of north American burn-care providers. Burns 2015; 41: 1442-1448.","journal-title":"Burns"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/14764172.2020.1761551","article-title":"Clinical efficacy of 1,444 nm Nd:YAG laser for xanthelasma palpebrarum","volume":"22","author":"JH","year":"2020","unstructured":"Park JH, Ryu SI and Kim IH. Clinical efficacy of 1,444 nm Nd:YAG laser for xanthelasma palpebrarum. J Cosmet Laser Ther 2020; 22: 141-145.","journal-title":"J Cosmet Laser Ther"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Park HS and Choi JW. Association between xanthelasma palpebrarum and the risk of ischemic heart diseases: a nationwide register-based cohort study. J Dermatol 2023; 50: e406-e408.","DOI":"10.1111\/1346-8138.16913"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10103-024-04273-y","article-title":"Effective treatment of xanthelasma palpebrarum using Er:YAG laser","volume":"40","author":"Park","year":"2025","unstructured":"Park H, Lee SB, Chung JH and Park SH. Effective treatment of xanthelasma palpebrarum using Er:YAG laser. Lasers Med Sci 2025; 40: 7.","journal-title":"Lasers Med Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/ddg.14879","article-title":"S2k guideline: laser therapy of the skin","volume":"20","author":"Paasch","year":"2022","unstructured":"Paasch U, Zidane M, Baron JM, Bund T, Cappius HJ, Drosner M, Feise K, Fischer T, Gauglitz G, Gerber PA, Grunewald S, Herberger K, Jung A, Karsai S, Kautz G, Philipp C, Schädel D, Seitz AT and Nast A. S2k guideline: laser therapy of the skin. J Dtsch Dermatol Ges 2022; 20: 1248-1267.","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Namazi N, Amani M, Haghighi Morad M and Namazi N. Is normolipidemic xanthelasma palpebrarum an independent risk factor of atherosclerosis? Int J Clin Pract 2021; 75: e14958.","DOI":"10.1111\/ijcp.14958"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/pin.13347","article-title":"Possible roles of human mast cells in the formation of xanthelasma palpebrarum","volume":"73","author":"Nakamura","year":"2023","unstructured":"Nakamura H, Matsuzaki T, Ito KR, Nakagawa R, Asano LM, Nishikido H, Haga H and Kataoka TR. Possible roles of human mast cells in the formation of xanthelasma palpebrarum. Pathol Int 2023; 73: 406-412.","journal-title":"Pathol Int"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Malekzadeh H, Ormseth B and Janis JE. A practical review of the management of xanthelasma palpebrarum. Plast Reconstr Surg Glob Open 2023; 11: e4982.","DOI":"10.1097\/GOX.0000000000004982"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ophtha.2024.07.033","article-title":"Association between xanthelasma palpebrarum with cardiovascular risk and dyslipidemia: a case control study","volume":"132","author":"Lustig-Barzelay","year":"2025","unstructured":"Lustig-Barzelay Y, Kapelushnik N, Goldshtein I, Leshno A, Segev S, Ben-Simon GJ and Landau-Prat D. Association between xanthelasma palpebrarum with cardiovascular risk and dyslipidemia: a case control study. Ophthalmology 2025; 132: 164-169.","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Lobato-Berezo A, March-Rodríguez Á, Pujol RM and Fernández-Figueras MT. Hemosiderotic Xanthelasmas. A new clinicopathological variant of xanthelasma palpebrarum or a localized variant of xanthosiderohistiocytosis of the eyelids? Am J Dermatopathol 2023; 45: 646-649.","DOI":"10.1097\/DAD.0000000000002514"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/wrr.12904","article-title":"Pulsed dye laser versus ablative fractional CO(2) laser in treatment of old hypertrophic scars: clinicopathological study","volume":"29","author":"Elgarhy","year":"2021","unstructured":"Elgarhy LH, El-Tatawy RA, Abdelaziz D and Dogheim NN. Pulsed dye laser versus ablative fractional CO(2) laser in treatment of old hypertrophic scars: clinicopathological study. Wound Repair Regen 2021; 29: 417-424.","journal-title":"Wound Repair Regen"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1007\/s00266-024-04435-x","article-title":"Aesthetic surgical treatment of large xanthelasma palpebrarum","volume":"48","author":"Lin","year":"2024","unstructured":"Lin Y and Wu L. Aesthetic surgical treatment of large xanthelasma palpebrarum. Aesthetic Plast Surg 2024; 48: 4828-4832.","journal-title":"Aesthetic Plast Surg"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1111\/jocd.13258","article-title":"Intralesional injection of bleomycin in the treatment of xanthelasma palpebrarum: a clinical study","volume":"19","author":"Lin","year":"2020","unstructured":"Lin X, Hu H, Qian Y, Jie X, Nie B, Zhao YZ, Wang H and Jiang H. Intralesional injection of bleomycin in the treatment of xanthelasma palpebrarum: a clinical study. J Cosmet Dermatol 2020; 19: 2125-2130.","journal-title":"J Cosmet Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Lee H and Cho S. Dyslipidemia may not be clinically relevant in treating xanthelasma palpebrarum: a retrospective pilot study. Dermatol Ther 2020; 33: e13589.","DOI":"10.1111\/dth.13589"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Konstantinou MP, Evangelou G, Hegazy S, Krasagakis K and Bulai-Livideanu C. Comparison of the efficacy and safety of continuous CO(2) laser and 1064 nm Q-switched Nd:YAG laser for the treatment of xanthelasma palpebrarum. Int J Dermatol 2023; 62: e120-e122.","DOI":"10.1111\/ijd.16475"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10103-025-04442-7","article-title":"Efficacy and safety of non-fractional ablative carbon dioxide laser resurfacing for the treatment of rhinophyma - a retrospective cohort and questionnaires-based study","volume":"40","author":"Noyman","year":"2025","unstructured":"Noyman Y, Friedman HO, Lapidoth M, Harris Rimon G, Solomon-Cohen E, Snast I, Rozenblat M, Mimouni D and Levi A. Efficacy and safety of non-fractional ablative carbon dioxide laser resurfacing for the treatment of rhinophyma - a retrospective cohort and questionnaires-based study. Lasers Med Sci 2025; 40: 261.","journal-title":"Lasers Med Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7181\/acfs.2022.00185","article-title":"Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum","volume":"23","author":"Kim","year":"2022","unstructured":"Kim YG, Oh JW, Lee KC and Yoon SH. Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum. Arch Craniofac Surg 2022; 23: 71-76.","journal-title":"Arch Craniofac Surg"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1347112","DOI":"10.3389\/fimmu.2024.1347112","article-title":"Genetic insight into putative causes of xanthelasma palpebrarum: a Mendelian randomization study","volume":"15","author":"Hu","year":"2024","unstructured":"Hu W, Liu Y, Lian C and Lu H. Genetic insight into putative causes of xanthelasma palpebrarum: a Mendelian randomization study. Front Immunol 2024; 15: 1347112.","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Goyal P, Gupta V, Aithal S, Meena D and Dhillon KS. Assessment and predictors of metabolic syndrome in patients of xanthelasma palpebrarum: an observational study. Dermatol Pract Concept 2024; 14: e2024218.","DOI":"10.5826\/dpc.1404a218"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.14744\/bej.2024.48802","article-title":"Complete blood cell count-derived inflammation biomarkers in patients with xanthelasma palpebrarum","volume":"9","author":"Ergun","year":"2024","unstructured":"Ergun SB and Kurt B. Complete blood cell count-derived inflammation biomarkers in patients with xanthelasma palpebrarum. Beyoglu Eye J 2024; 9: 33-37.","journal-title":"Beyoglu Eye J"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"4803168","DOI":"10.1155\/2020\/4803168","article-title":"A modified surgical method combined with blepharoplasty design for treatment of xanthelasma palpebrarum","volume":"2020","author":"EJ","year":"2020","unstructured":"Choi EJ, Oh TM and Han HH. A modified surgical method combined with blepharoplasty design for treatment of xanthelasma palpebrarum. Biomed Res Int 2020; 2020: 4803168.","journal-title":"Biomed Res Int"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/8\/ajtr0166083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:00:06Z","timestamp":1766023206000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/8\/ajtr0166083.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/detb5846","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}